The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Aptamers and the next generation of diagnostic reagents
Open accessAbstract
Antibodies have been extensively used as capture and detection reagents in diagnostic applications of proteomics‐based technologies. Proteomic assays need high sensitivity and specificity, a wide dynamic range for detection, and accurate, reproducible quantification with small confidence values. However, several inherent limitations of monoclonal antibodies in meeting the emerging challenges of proteomics led to the development of a new class of oligonucleotide‐based reagents. Natural and derivatized nucleic acid aptamers are emerging as promising alternatives to monoclonal antibodies. Aptamers can be effectively used to simultaneously detect thousands of proteins in multiplex discovery platforms, where antibodies often fail due to cross‐reactivity problems. Through chemical modification, vast range of additional functional groups can be added at any desired position in the oligonucleotide sequence, therefore the best features of small molecule drugs, proteins, and antibodies can be brought together into aptamers, making aptamers the most versatile reagent in proteomics. In this review, we discuss the recent developments in aptamer technology, including new selection methods and the aptamers’ application in proteomics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Neutralizing Aptamers from Whole-Cell SELEX Inhibit the RET Receptor Tyrosine Kinase
Cerchia, L., Ducongé, F., Pestourie, C., Boulay, J., Aissouni, Y., Gombert, K., Tavitian, B., de Franciscis, V., & Libri, D. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030123 · Cited by 246
RetractedTuerk, C., & Gold, L. (1990) · Science · doi:10.1126/science.2200121 · Cited by 10,405
In vitro selection of RNA molecules that bind specific ligands
Ellington, A. D., & Szostak, J. W. (1990) · Nature · doi:10.1038/346818a0 · Cited by 9,812
Keefe, A. D., Pai, S., & Ellington, A. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3141 · Cited by 2,289
Aptamers: An Emerging Class of Molecules That Rival Antibodies in Diagnostics
Jayasena, S. D. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.9.1628 · Cited by 2,144
Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
Gold, L., Ayers, D., Bertino, J., Bock, C., Bock, A., Brody, E. N., Carter, J., Dalby, A. B., Eaton, B. E., Fitzwater, T., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015004 · Cited by 1,754
Adaptive Recognition by Nucleic Acid Aptamers
Hermann, T., & Patel, D. J. (2000) · Science · doi:10.1126/science.287.5454.820 · Cited by 1,650
‘Click’ Chemistry in Polymer and Materials Science
Binder, W. H., & Sachsenhofer, R. (2007) · Macromolecular Rapid Communications · doi:10.1002/marc.200600625 · Cited by 1,561
Aptamers evolved from live cells as effective molecular probes for cancer study
Shangguan, D., Li, Y., Tang, Z., Cao, Z. C., Chen, H. W., Mallikaratchy, P., Sefah, K., Yang, C. J., & Tan, W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602615103 · Cited by 1,516
Protein detection using proximity-dependent DNA ligation assays
Fredriksson, S., Gullberg, M., Jarvius, J., Olsson, C., Pietras, K., Gústafsdóttir, S. M., Östman, A., & Landegren, U. (2002) · Nature Biotechnology · doi:10.1038/nbt0502-473 · Cited by 1,504
In Vitro Selection of Functional Nucleic Acids
Wilson, D. S., & Szostak, J. W. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.611 · Cited by 1,206
High-Resolution Molecular Discrimination by RNA
Jenison, R. D., Gill, S. C., Pardi, A., & Polisky, B. (1994) · Science · doi:10.1126/science.7510417 · Cited by 1,188
Aptamers Generated from Cell-SELEX for Molecular Medicine: A Chemical Biology Approach
Fang, X., & Tan, W. (2010) · Accounts of Chemical Research · doi:10.1021/ar900101s · Cited by 747
Multiplexed protein profiling on microarrays by rolling-circle amplification
Schweitzer, B., Roberts, S., Grimwade, B., Shao, W., Wang, M., Fu, Q., Shu, Q., Laroche, I., Zhou, Z., Tchernev, V. T., et al. (2002) · Nature Biotechnology · doi:10.1038/nbt0402-359 · Cited by 573
Daniels, D. A., Chen, H., Hicke, B. J., Swiderek, K. M., & Gold, L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2136683100 · Cited by 567
Aptamers as therapeutic and diagnostic agents
Brody, E. N., & Gold, L. (2000) · Reviews in Molecular Biotechnology · doi:10.1016/s1389-0352(99)00004-5 · Cited by 494
Discovery and development of anticancer aptamers
Ireson, C. R., & Kelland, L. R. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0172 · Cited by 481
Kinetic Characterization of Ribonuclease-Resistant 2′-Modified Hammerhead Ribozymes
Pieken, W. A., Olsen, D. B., Benseler, F., Aurup, H., & Eckstein, F. (1991) · Science · doi:10.1126/science.1857967 · Cited by 463
Demko, Z., & Sharpless, K. B. (2002) · PubMed · Cited by 447
RNA pseudoknots that inhibit human immunodeficiency virus type 1 reverse transcriptase.
Tuerk, C., MacDougal, S., & Gold, L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.6988 · Cited by 415
Postsynthetic DNA Modification through the Copper‐Catalyzed Azide–Alkyne Cycloaddition Reaction
Gramlich, P. M. E., Wirges, C. T., Manetto, A., & Carell, T. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200802077 · Cited by 406
Regulation of Gene Expression with Double-Stranded Phosphorothioate Oligonucleotides
Bielinska, A., Shivdasani, R. A., Zhang, L., & Nabel, G. J. (1990) · Science · doi:10.1126/science.2237444 · Cited by 372
Geiger, A. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.6.1029 · Cited by 368
Automated selection of anti-Protein aptamers
Cox, J. C., & Ellington, A. D. (2001) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(01)00028-1 · Cited by 367
FluMag-SELEX as an advantageous method for DNA aptamer selection
Stoltenburg, R., Reinemann, C., & Strehlitz, B. (2005) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-005-3388-9 · Cited by 367
An enzyme-linked oligonucleotide assay
Drolet, D. W., Moon-McDermott, L., & Romig, T. S. (1996) · Nature Biotechnology · doi:10.1038/nbt0896-1021 · Cited by 335
Systematic Evolution of a DNA Aptamer Binding to Rat Brain Tumor Microvessels
Blank, M., Weinschenk, T., Priemer, M., & Schluesener, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100347200 · Cited by 326
Antibodies in diagnostics – from immunoassays to protein chips
Borrebaeck, C. A. K. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01683-2 · Cited by 324
Tenascin-C Aptamers Are Generated Using Tumor Cells and Purified Protein
Hicke, B. J., Marion, C., Chang, Y.-F., Gould, T., Lynott, C. K., Parma, D., Schmidt, P. G., & Warren, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104651200 · Cited by 324
Discovery and Development of Therapeutic Aptamers
Bouchard, P. R., Hutabarat, R. M., & Thompson, K. M. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105547 · Cited by 320
Identification of Liver Cancer-Specific Aptamers Using Whole Live Cells
Shangguan, D., Meng, L., Cao, Z. C., Xiao, Z., Fang, X., Li, Y., Cardona, D., Witek, R. P., Liu, C., & Tan, W. (2008) · Analytical Chemistry · doi:10.1021/ac701962v · Cited by 316
Expanding the Chemistry of DNA for in Vitro Selection
Vaught, J. D., Bock, C., Carter, J., Fitzwater, T., Otis, M., Schneider, D., Rolando, J., Waugh, S., Wilcox, S. K., & Eaton, B. E. (2010) · Journal of the American Chemical Society · doi:10.1021/ja908035g · Cited by 313
Aptamer-Based Sensor Arrays for the Detection and Quantitation of Proteins
Kirby, R., Cho, E. J., Gehrke, B., Bayer, T., Park, Y. S., Neikirk, D. P., McDevitt, J. T., & Ellington, A. D. (2004) · Analytical Chemistry · doi:10.1021/ac049858n · Cited by 313
Kraemer, S., Vaught, J. D., Bock, C., Gold, L., Katilius, E., Keeney, T. R., Kim, N., Saccomano, N. A., Wilcox, S. K., Zichi, D., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026332 · Cited by 310
Developing aptamers into therapeutics
White, R. R., Sullenger, B. A., & Rusconi, C. P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11325 · Cited by 295
Application of locked nucleic acids to improve aptamer in vivo stability and targeting function
Schmidt, K. S. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh862 · Cited by 287
SELEX with modified nucleotides
Keefe, A. D., & Cload, S. T. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.06.028 · Cited by 283
Aptamer-based biosensor arrays for detection and quantification of biological macromolecules
McCauley, T. G., Hamaguchi, N., & Stanton, M. (2003) · Analytical Biochemistry · doi:10.1016/s0003-2697(03)00297-5 · Cited by 266
Joshi, R., Janagama, H., Dwivedi, H. P., Senthil Kumar, T. M. A., Jaykus, L.-A., Schefers, J., & Sreevatsan, S. (2009) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2008.10.006 · Cited by 265
Molecular recognition of acute myeloid leukemia using aptamers
Sefah, K., Tang, Z. W., Shangguan, D. H., Chen, H., Lopez-Colon, D., Li, Y., Parekh, P., Martin, J., Meng, L., Phillips, J. A., et al. (2009) · Leukemia · doi:10.1038/leu.2008.335 · Cited by 226
Bioactive and nuclease-resistant l -DNA ligand of vasopressin
Williams, K. P., Liu, X.-H., Schumacher, T. N. M., Lin, H. Y., Ausiello, D. A., Kim, P. S., & Bartel, D. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11285 · Cited by 222
Let's get specific: the relationship between specificity and affinity
Eaton, B. E., Gold, L., & Zichi, D. A. (1995) · Chemistry & Biology · doi:10.1016/1074-5521(95)90023-3 · Cited by 218
Ostroff, R., Bigbee, W., Franklin, W., Gold, L., Mehan, M., Miller, Y., Pass, H., Rom, W., Siegfried, J., Stewart, A., et al. (2010) · Nature Precedings · doi:10.1038/npre.2010.4537.1 · Cited by 213
The use of aptamers in large arrays for molecular diagnostics
BRODY, E., WILLIS, M., SMITH, J., JAYASENA, S., ZICHI, D., & GOLD, L. (1999) · Molecular Diagnosis · doi:10.1016/s1084-8592(99)80014-9 · Cited by 210
Aptamer-Facilitated Biomarker Discovery (AptaBiD)
Berezovski, M. V., Lechmann, M., Musheev, M. U., Mak, T. W., & Krylov, S. N. (2008) · Journal of the American Chemical Society · doi:10.1021/ja801951p · Cited by 198
Multiplexed protein detection by proximity ligation for cancer biomarker validation
Fredriksson, S., Dixon, W., Ji, H., Koong, A. C., Mindrinos, M., & Davis, R. W. (2007) · Nature Methods · doi:10.1038/nmeth1020 · Cited by 196
Three small ribooligonucleotides with specific arginine sites
Connell, G. J., Illangesekare, M., & Yarus, M. (1993) · Biochemistry · doi:10.1021/bi00072a002 · Cited by 183
CELL-SELEX: Novel Perspectives of Aptamer-Based Therapeutics
Guo, K.-T., Ziemer, G., Paul, A., & Wendel, H. P. (2008) · International Journal of Molecular Sciences · doi:10.3390/ijms9040668 · Cited by 169
Anti‐VEGF Aptamer (Pegaptanib) Therapy for Ocular Vascular Diseases
NG, E. W. M., & ADAMIS, A. P. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1348.062 · Cited by 161
Selection of fluorescent aptamer beacons that light up in the presence of zinc
Rajendran, M., & Ellington, A. D. (2008) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-007-1735-8 · Cited by 159
Cox, J. C., Rudolph, P., & Ellington, A. D. (1998) · Biotechnology Progress · doi:10.1021/bp980097h · Cited by 156
Production and processing of aptamer microarrays
Collett, J. R., Cho, E. J., & Ellington, A. D. (2005) · Methods · doi:10.1016/j.ymeth.2005.05.009 · Cited by 152
Francica, J. R., Varela‐Rohena, A., Medvec, A. R., Plesa, G., Riley, J. L., & Bates, P. F. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001098 · Cited by 146
Photoaptamer arrays applied to multiplexed proteomic analysis
Bock, C., Coleman, M., Collins, B. D., Davis, J., Foulds, G., Gold, L., Greef, C., Heil, J., Heilig, J. S., Hicke, B. J., et al. (2004) · PROTEOMICS · doi:10.1002/pmic.200300631 · Cited by 144
Design and characterization of decoy oligonucleotides containing locked nucleic acids
Crinelli, R., Bianchi, M., Gentilini, L., & Magnani, M. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.11.2435 · Cited by 143
Eulberg, D. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni044 · Cited by 140
Generating Aptamers for Recognition of Virus-Infected Cells
Tang, Z., Parekh, P. A., Turner, P., Moyer, R. W., & Tan, W. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.113514 · Cited by 139
Iterative In Situ Click Chemistry Creates Antibody‐like Protein‐Capture Agents
Agnew, H. D., Rohde, R. D., Millward, S. W., Nag, A., Yeo, W., Hein, J. E., Pitram, S. M., Tariq, A. A., Burns, V. M., Krom, R. J., et al. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200900488 · Cited by 131
High-affinity RNA ligands to human α-thrombin
Kubik, M. F., Stephens, A. W., Schneider, D., Marlar, R. A., & Tasset, D. M. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.13.2619 · Cited by 129
Aptamers as tools for target validation
Blank, M., & Blind, M. (2005) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2005.06.011 · Cited by 128
Isolation of virus-neutralizing RNAs from a large pool of random sequences.
Pan, W., Craven, R. C., Qiu, Q., Wilson, C. B., Wills, J. W., Golovine, S., & Wang, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11509 · Cited by 120
In Vitro Selection of RNA Ligands to Substance P
Nieuwlandt, D., Wecker, M. S. A., & Gold, L. (1995) · Biochemistry · doi:10.1021/bi00016a041 · Cited by 119
Selection and Characterization of an RNA Decoy for Transcription Factor NF-κB
Lebruska, L. L., & Maher, L. J. (1999) · Biochemistry · doi:10.1021/bi982515x · Cited by 117
Mann, A. P., Somasunderam, A., Nieves-Alicea, R., Li, X., Hu, A. H., Sood, A. K., Mauro Ferrari, B., Gorenstein, D. G., & Tanaka, T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013050 · Cited by 106
Self-citationCombinatorial Selection of DNA Thioaptamers Targeted to the HA Binding Domain of Human CD44
Somasunderam, A., Thiviyanathan, V., Tanaka, T., Li, X., Neerathilingam, M., Lokesh, G. L.-R., Mann, A. P., Peng, Y., Mauro Ferrari, B., Klostergaard, J., et al. (2010) · Biochemistry · doi:10.1021/bi1009503 · Cited by 103
Self-citationTechnical and Biological Issues Relevant to Cell Typing with Aptamers
Li, N., Ebright, J. N., Stovall, G. M., Chen, X., Nguyen, H. H., Singh, A., Syrett, H. A., & Ellington, A. D. (2009) · Journal of Proteome Research · doi:10.1021/pr801048z · Cited by 100
Novel Combinatorial Selection of Phosphorothioate Oligonucleotide Aptamers
King, D. J., Ventura, D. A., Brasier, A. R., & Gorenstein, D. G. (1998) · Biochemistry · doi:10.1021/bi981780f · Cited by 100
Self-citationLNA/DNA chimeric oligomers mimic RNA aptamers targeted to the TAR RNA element of HIV-1
Darfeuille, F. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh636 · Cited by 97
Molecular Imaging with Nucleic Acid Aptamers
Hong, H., Goel, S., Zhang, Y. E., & Cai, W. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711797189691 · Cited by 96
Thioaptamer Conjugated Liposomes for Tumor Vasculature Targeting
Mann, A. P., Bhavane, R. C., Somasunderam, A., Montalvo-Ortiz, B. L., Ghaghada, K. B., Volk, D. E., Nieves-Alicea, R., Suh, K. S., Mauro Ferrari, B., Annapragada, A., et al. (2010) · Oncotarget · doi:10.18632/oncotarget.261 · Cited by 91
Self-citationRNA and DNA aptamers in cytomics analysis
Ulrich, H., Martins, A. H. B., & Pesquero, J. B. (2004) · Cytometry Part A · doi:10.1002/cyto.a.20056 · Cited by 83
Aptamers: a new class of oligonucleotides in the drug discovery pipeline?
Dausse, E., Gomes, S. D. R., & Toulmé, J. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.07.006 · Cited by 81
Ni2+-binding RNA motifs with an asymmetric purine-rich internal loop and a G-A base pair.
Hofmann, H. P., Limmer, S., Hornung, V., & Sprinzl, M. (1997) · PubMed · Cited by 80
Immunofluorescence assay and flow-cytometry selection of bead-bound aptamers
Yang, X. (2003) · Nucleic Acids Research · doi:10.1093/nar/gng054 · Cited by 76
Yang, X. (2002) · Nucleic Acids Research · doi:10.1093/nar/gnf132 · Cited by 74
High-content affinity-based proteomics: unlocking protein biomarker discovery
Brody, E. N., Gold, L., Lawn, R. M., Walker, J. J., & Zichi, D. (2010) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.10.89 · Cited by 74
T7 RNA Polymerase Transcription with 5-Position Modified UTP Derivatives
Vaught, J. D., Dewey, T. M., & Eaton, B. E. (2004) · Journal of the American Chemical Society · doi:10.1021/ja049009h · Cited by 69
Combinatorial selection of a single stranded DNA thioaptamer targeting TGF-β1 protein
Kang, J., Lee, M. S., Copland, J. A., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.02.023 · Cited by 67
Aptamers as molecular tools for bioanalytical methods.
Tombelli, S., & Mascini, M. (2009) · PubMed · Cited by 65
In vitro selection of phosphorothiolated aptamers
Jhaveri, S. D., Olwin, B. B., & Ellington, A. D. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00414-4 · Cited by 64
Modulating the pharmacokinetics of therapeutic antibodies
Constantinou, A., Chen, C., & Deonarain, M. P. (2010) · Biotechnology Letters · doi:10.1007/s10529-010-0214-z · Cited by 58
Aptamer evolution for array-based diagnostics
Platt, M., Rowe, W., Wedge, D. C., Kell, D. B., Knowles, J. D., & Day, P. J. (2009) · Analytical Biochemistry · doi:10.1016/j.ab.2009.04.013 · Cited by 56
Immunohistology—Past, Present, and Future
Leong, T. Y.-M., Cooper, K., & Leong, A. S. ‐. (2010) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e3181f8957c · Cited by 54
The Robustness of Naturally and Artificially Selected Nucleic Acid Secondary Structures
Ancel, L. W., Lee, J. F., Cowperthwaite, M. C., & Ellington, A. D. (2004) · Journal of Molecular Evolution · doi:10.1007/s00239-004-2590-2 · Cited by 53
Somasunderam, A., Ferguson, M. R., Rojo, D. R., Thiviyanathan, V., Li, X., O’Brien, W. A., & Gorenstein, D. G. (2005) · Biochemistry · doi:10.1021/bi0507074 · Cited by 52
Self-citationTowards the selection of phosphorothioate aptamers
Andréola, M., Calmels, C., Bertrand‐Michel, J., Toulmé, J., & Litvak, S. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01557.x · Cited by 50
Thioaptamer Interactions with Prion Proteins: Sequence-specific and Non-specific Binding Sites
King, D. J., Safar, J., Legname, G., & Prusiner, S. B. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.02.004 · Cited by 49
Zhao, Y., Widen, S. G., Jamaluddin, M., Tian, B., Wood, T. G., Edeh, C. B., & Brasier, A. R. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.008771 · Cited by 47
Strategies for the discovery of therapeutic aptamers
Yang, X., Li, N., & Gorenstein, D. G. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.537321 · Cited by 46
Self-citationBridonneau, P., Chang, Y.-F., O'Connell, D., Gill, S. C., Snyder, D. W., Johnson, L. M., Goodson, T. G., III, Herron, D. K., & Parma, D. H. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970579k · Cited by 36
Kang, J., Lee, M. S., Watowich, S. J., & Gorenstein, D. G. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.04.072 · Cited by 34
Self-citationFennewald, S. M., Scott, E. P., Zhang, L., Yang, X., Aronson, J. F., Gorenstein, D. G., Luxon, B. A., Shope, R. E., Beasley, D. W. C., Barrett, A. D. T., et al. (2007) · Journal of General Virology · doi:10.1099/vir.0.82499-0 · Cited by 33
Self-citationThe pre‐omics era: The early days of two‐dimensional gels
O’Farrell, P. H. (2008) · PROTEOMICS · doi:10.1002/pmic.200800719 · Cited by 29
Sugar boost: when ribose modifications improve oligonucleotide performance.
Faria, M., & Ulrich, H. (2008) · PubMed · Cited by 28
Improving monoclonal antibody pharmacokinetics via chemical modification.
Sharifi, J., Khawli, L. A., Hornick, J. L., & Epstein, A. L. (1998) · PubMed · Cited by 25
Aptamers as Affinity Reagents in an Integrated Electrophoretic Lab-on-a-Chip Platform
Hecht, A., Sommer, G. J., Durland, R. H., Yang, X., Singh, A. K., & Hatch, A. V. (2010) · Analytical Chemistry · doi:10.1021/ac101106m · Cited by 24
Kräemer, S., Vaught, J. D., Bock, C., Gold, L., Katilius, E., Keeney, T. R., Kim, N., Saccomano, N. A., Wilcox, S. K., Zichi, D., et al. (2010) · Nature Precedings · doi:10.1038/npre.2010.4642.1 · Cited by 5
Cited by
Detection and beyond: challenges and advances in aptamer-based biosensors
Yoo, H., Jo, H., & Oh, S. S. (2020) · Materials Advances · doi:10.1039/d0ma00639d · Cited by 334
Aptamer Selection Technology and Recent Advances
Blind, M., & Blank, M. (2015) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2014.74 · Cited by 322
Philip, A., & Kumar, A. R. (2022) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2022.214424 · Cited by 281
Nucleic acid aptamers in cancer research, diagnosis and therapy
Ma, H., Liu, J., Ali, M. M., Mahmood, M. A. I., Labanieh, L., Lu, M., Iqbal, S. M., Zhang, Q., Zhao, W., & Wan, Y. (2015) · Chemical Society Reviews · doi:10.1039/c4cs00357h · Cited by 265
RNA self-processing: formation of cyclic species and concatemers from a small engineered RNA
Petkovic, S., & Müller, S. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.06.013 · Cited by 41
Metadata
- Authors
- Thiviyanathan, V., & Gorenstein, D. G.
- Venue
- PROTEOMICS – Clinical Applications
- Publisher
- Wiley
- Published
- 2012-12
- Volume
- 6
- Issue
- 11-12
- Pages
- 563-573
- ISSN
- 1862-8346 (ISSN-L)
- 1862-8354
- OpenAlex
- W2125029325
- Cited by
- 275
- References
- 97
- FWCI
- 1.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.